story of the week
Defining Genomic, Transcriptomic, Proteomic, Epigenetic, and Phenotypic Biomarkers With Prognostic Capability in Male Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer: a systematic review
Lancet Oncol 2023 Feb 01;24(2)e74-e85, S Chatterji, E Krzoska, CW Thoroughgood, J Saganty, P Liu, B Elsberger, R Abu-Eid, V SpeirsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.